Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma
- PMID: 18550101
- DOI: 10.1016/j.juro.2008.04.034
Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma
Abstract
Purposes: It is controversial that perinephric fat infiltration has an impact on survival in patients with renal cell carcinoma. Therefore, we evaluated the influence of perinephric fat infiltration and tumor size on patient survival.
Materials and methods: We retrospectively reviewed the medical records of 783 and 77 patients with pT1-2 (cN0M0) and pT3a (cN0M0) renal cell carcinoma, respectively. Sporadic unilocular noncystic renal cell carcinoma was included. Univariate and multivariate analyses of prognostic factors, including perinephric fat infiltration, on cancer specific and disease-free survival were performed. Median followup was 56.0 months after surgery.
Results: Patients with pT1-2 and pT3a tumors had a 5-year cancer specific survival rate of 96.1% and 84.9%, and a 5-year disease-free survival rate of 93.4% and 74.7%, respectively (each p <0.01). Age, tumor size and Fuhrman nuclear grade were independent prognostic factors for cancer specific and disease-free survival, whereas perinephric fat infiltration was significant only for disease-free survival. However, perinephric fat infiltration had a significant effect on cancer specific survival in patients with pT3a tumors more than 7 cm (p = 0.001). In contrast, patients with pT3a tumors 7 cm or less had cancer specific and disease-free survival similar to that of patients with pT2 tumors. Recurrence of pT3a tumors greater than 7 cm was observed in 44% of patients but in only 14.6% of those with pT3a tumors 7 cm or less (p = 0.029). In contrast to the recurrence of tumors 7 cm or less, recurrence of pT3a tumors more than 7 cm usually developed at multiple sites with a large tumor burden and it progressed rapidly. Consequently 85% of patients with recurrence of pT3a tumors larger than 7 cm died of renal cell carcinoma compared with 33% of those with recurrence of pT3a tumors 7 cm or less (p = 0.001).
Conclusions: In pT3a renal cell carcinoma tumor size was the strongest prognostic factor of disease-free and cancer specific survival. Perinephric fat infiltration was an independent prognostic factor for disease-free survival but not for cancer specific survival due to the less aggressive behavior of small (7 cm or less) pT3a tumors after recurrence. Tumor size and perinephric fat infiltration should be included in T3a renal cell carcinoma staging.
Similar articles
-
Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.J Urol. 2007 Nov;178(5):1878-82. doi: 10.1016/j.juro.2007.07.011. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868733
-
Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286201
-
Reevaluation of renal cell carcinoma and perirenal fat invasion only.J Urol. 2009 Nov;182(5):2137-43. doi: 10.1016/j.juro.2009.07.065. Epub 2009 Sep 16. J Urol. 2009. PMID: 19758661
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma.Urology. 2004 Feb;63(2):235-9; discussion 239-40. doi: 10.1016/j.urology.2003.09.081. Urology. 2004. PMID: 14972460 Review.
Cited by
-
Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.PLoS One. 2017 Mar 13;12(3):e0173953. doi: 10.1371/journal.pone.0173953. eCollection 2017. PLoS One. 2017. PMID: 28288191 Free PMC article.
-
Prognostic significance of perirenal infiltration in renal cell carcinoma (<7 cm).Yonsei Med J. 2012 Sep;53(5):940-3. doi: 10.3349/ymj.2012.53.5.940. Yonsei Med J. 2012. PMID: 22869476 Free PMC article.
-
The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.Cancer Med. 2021 Jan;10(2):605-614. doi: 10.1002/cam4.3629. Epub 2020 Dec 6. Cancer Med. 2021. PMID: 33280246 Free PMC article.
-
Prognostic factors in renal cell carcinoma: A single‑center study.Mol Clin Oncol. 2023 Jul 14;19(3):66. doi: 10.3892/mco.2023.2662. eCollection 2023 Sep. Mol Clin Oncol. 2023. PMID: 37614366 Free PMC article.
-
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patients.Int J Clin Oncol. 2025 Jul 14. doi: 10.1007/s10147-025-02825-y. Online ahead of print. Int J Clin Oncol. 2025. PMID: 40658306
MeSH terms
LinkOut - more resources
Full Text Sources
Medical